Immune System Disorder, Platelet Abnormality, Renal Failure
Conditions
Brief summary
Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflammatory cytokines. Data obtained from hemograms, such as platelet lymphocytosis ratio, are used in the diagnosis or prognosis of many diseases. This study focuses on the change in hemogram rates in patients who received hemofiltration and sepsis filters.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Data of patients who were monitored in the Intensive Care between January 2020 and December 2022 and who were applied sepsis filters
Exclusion criteria
* -Patients who underwent hemodiafiltration with sepsis filter but could not be followed for 72 hours (death, etc.)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Platelet lymphocyte ratio change | up to 72 hours | Change in platelet lymphocyte ratio measured from hemogram at the beginning (day 0) and the ratio calculated from the sample taken on day 3 in patients undergoing hemodiafiltration with sepsis filter |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| change in the other ratios derived from complete blood cell count | up to 72 hours | Changes in hemogram derivation ratios measured from the hemogram at the beginning (day 0) and the ratio calculated from the sample taken on day 3 in patients who underwent hemodiafiltration with sepsis filter |
Countries
Turkey (Türkiye)